- Rank: 53
- Followers: 9
- Votes: 5
- Years Member: 3
- Last Update: 28 July 2020, 15:00
Support / Resistance Lines
7/15/2020: With the news of Moderna%27s late stage vaccine trials, it%27s time to rotate back into the Coronavirus Epicenter stocks, it%27s decent timing from a risk perspective also because all of these stocks have pulled back a lot since their prior surge. A good basket is UAL, NCLH, DENN, MGM, UWM is also interesting (leveraged Russel 2K)
Strategy based on these assumptions:
- Coming into this crisis, economy was stronger than it has been in quite some time, maybe decades?
- Government taking steps protect credit markets and financial system, we%27re not talking depression here, no reason the market will not revisit its recent highs within a year or so.
- Low oil prices (~$40 or lower) will be here for a while, reduces cost of business.
- Extremely low interest rates will fuel a ripping economy when things clear.
- Don%27t retirement money for years.
Strategy as consists of 4 parts:
1. Tech Heavyweights: Strong long-term uptrends coming into pandemic. ADBE, NOW, CRM, MSFT, AVGO, SWKS, TLSA, etc. Target 50% of portfolio.
2. Metals: Silver still oversold long-term by all tradition measures, the silver/gold price ratio per ounce (see chart) is at levels we haven%27t even come close to in the 50 years. A world back to work also needs copper. Watching for another Palladium pullback. Target 15% of portfolio.
3. Growth & stability at a value: Companies on strong long-term up-trends coming into this but have taken a big hit, generally rounds out the diversification of the portfolio. Idustrials (RTX, X, NUE, LIN), energy (CVX, COP, PSX), medical, consumer, etc. Ignoring defensive stocks that may do well while the pandemic goes on because I am looking for long-term return. Target 20%
4. Coronavirus Epicenter stocks: Airlines, casinos, restaurants, etc.. Target: 15%
5. Cash: 0%
Watching these stocks for entry points.
This information is presented for education purposes only. StockCharts.com is not responsible for any comments, advice, or annotations presented on this page. Please review our Terms of Service for more details.